Insider trade

Director sold ~$140K of CME shares in the open market

Traded Sep 14, 2026 · Filed Sep 15, 2026

CME GroupCME

~$140K
Reported value · 500 sh @ $280.11: 18K
Holds after · shares reported: -3.7%
stock since the trade · S&P 500 +1.8%, $280.46 → $270.03 on Oct 5

Why it stands out

A board member of CME Group sold $140K of CME Group shares. Nobody planned it ahead of time.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Sep 14, 2026
Reporting period: Not applicable
Filed with the SEC: Sep 15, 2026

DirectorIndirect holding$100K–$500K

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$140,055

Shares × reported transaction price

Timing vs results

54 days after results of Jul 22, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $280.46 on Sep 14, 2026, 28% above its 52-week low and 14% below its high, after a 5% rise over the previous 30 trading days

52-week range $218.58 (Jun 29, 2026) to $326.46 (Mar 2, 2026), 57% of the way up, from 251 adjusted closes. 30 trading days earlier: $267.79 on Jul 31, 2026. Describes the past only, not a forecast

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

Securities lawsuit open at the trade date

A securities lawsuit naming the company as a defendant was filed on Jun 14, 2024 in the U.S. District Court, S.D. New York. A filing is an allegation, not a finding.

Global Carbon Opportunity (Cayman) Fund Ltd. v. CME Group Inc., docket 1:24-cv-04562, via CourtListener (court records). Nature of suit 850, company named as first defendant